Objectives:

  • Identify important changes made to the 2019 State of IL Perinatal HIV Guidelines
  • Correctly apply the 2019 State of IL Perinatal HIV Guidelines to neonates born to HIV-infected women at UCMC
  • Provide culturally-sensitive guidance to health care workers faced with important decisions around providing care to HIV-infected women and their neonates.
  • - review previous RTCs related to treatment for ROP
  • - understand risks and benefits of anti-VEGF agents
  • - consider the potential effects of anti-VEGF agents on neurodevelopment 
  • - review a possible prospective RTC using a new anti-VEGF agent

 

Session date: 
Thursday, November 14, 2019 - 1:30pm to 3:00pm
Speaker Name: 
Julia Rosebush, DO & Sarah Rodriquez, MD
Location: 
UCMC K-287
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.